⚞(⦾.⦾)⚟ | $LABU $LABD | MA + RSI | v0.5
Today’s Change (Apr 20, 2026)
—
A symphony is an automated trading strategy — Learn more about symphonies here
About
A daily biotech trend rider using 3x bull/bear ETFs. Trades LABU when short-term biotech trend is up, may flip to LABD on overbought wobble, and holds QQQ when no biotech uptrend. Uses very short moving averages and a short RSI. Very high risk.
It trades the biotech sector using 3x ETFs: LABU (goes up when biotech rises) and LABD (goes up when biotech falls). If biotech’s short-term trend (2-day avg) isn’t above its 10-day avg, it parks in QQQ (big-tech). In uptrends it mostly holds LABU. If price gets very “hot” (RSI, a 0–100 heat gauge, is high), it uses tiny trend checks (2 vs 3-day averages) to flip briefly to LABD or back to LABU. Rebalances daily.
Out-of-sample edge: ~75% annualized return with Sharpe ~1.25 and Calmar ~2.63, beating SPY on risk-adjusted terms. Higher drawdown (~28% vs ~19%). For volatility-tolerant investors, biotech-trend alpha offers stronger upside than the S&P 500.
1M
3M
6M
YTD
1Y
3Y
Max
Performance
Compared to selected benchmarks
| Alpha | Beta | R2 | R | |
|---|---|---|---|---|
| -0.09 | 1.56 | 0.18 | 0.43 |
Performance Metrics
| Cumulative Return | Annualized Return | Trailing 1M Return | Trailing 3M Return | Sharpe Ratio | |
|---|---|---|---|---|---|
| 316.53% | 14.36% | 6.16% | 5.09% | 0.84 | |
| -54.91% | -7.22% | 10.73% | -9.55% | 0.21 |
Initial Investment
$10,000.00
Final Value
$4,509.02Regulatory Fees
$125.95
Total Slippage
$849.89
Invest in this strategy
OOS Start Date
Oct 17, 2024
Trading Setting
Daily
Type
Stocks
Category
Trend-following, biotech, leveraged etfs, momentum, rsi, moving averages, tactical allocation, long/short, daily rebalance